M

MaxCyte Inc
NASDAQ:MXCT

Watchlist Manager
MaxCyte Inc
NASDAQ:MXCT
Watchlist
Price: 4.115 USD 1.35%
Market Cap: 434.1m USD
Have any thoughts about
MaxCyte Inc?
Write Note

Relative Value

The Relative Value of one MXCT stock under the Base Case scenario is 3.366 USD. Compared to the current market price of 4.115 USD, MaxCyte Inc is Overvalued by 18%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MXCT Relative Value
Base Case
3.366 USD
Overvaluation 18%
Relative Value
Price
M
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
52
vs Industry
18
Median 3Y
10.6
Median 5Y
8.6
Industry
4.1
Forward
11.1
vs History
vs Industry
Median 3Y
-14.5
Median 5Y
-28.9
Industry
32.7
Forward
-9.6
vs History
vs Industry
Median 3Y
-27.6
Median 5Y
-89.9
Industry
22.1
vs History
vs Industry
Median 3Y
-18.4
Median 5Y
-25.2
Industry
33.6
vs History
60
vs Industry
48
Median 3Y
2.1
Median 5Y
1.9
Industry
2.6
vs History
47
vs Industry
23
Median 3Y
6.3
Median 5Y
4.4
Industry
3.9
Forward
7.1
vs History
47
vs Industry
46
Median 3Y
7.2
Median 5Y
5
Industry
8.6
vs History
vs Industry
Median 3Y
-8.3
Median 5Y
-19.2
Industry
18.5
Forward
-7.6
vs History
vs Industry
Median 3Y
-7.5
Median 5Y
-17.6
Industry
23.7
Forward
-5
vs History
vs Industry
Median 3Y
-15
Median 5Y
-50.7
Industry
21.4
vs History
vs Industry
Median 3Y
-11.5
Median 5Y
-16
Industry
28.8
vs History
63
vs Industry
29
Median 3Y
4.6
Median 5Y
3.2
Industry
2.4

Multiples Across Competitors

MXCT Competitors Multiples
MaxCyte Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
MaxCyte Inc
NASDAQ:MXCT
427m USD 9.5 -12.1 -6.5 -5.9
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 448.2 4 796.2 1 513.6 3 225.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
200.4B USD 4.7 32.7 21.2 30.4
US
Danaher Corp
NYSE:DHR
165.4B USD 7.8 42.5 26.7 40.1
KR
Samsung Biologics Co Ltd
KRX:207940
66.8T KRW 15.3 63.4 34.3 49.4
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.5B USD 5.9 29.9 22.3 25.9
US
IQVIA Holdings Inc
NYSE:IQV
35.9B USD 2.4 25.7 14.1 21.5
US
Mettler-Toledo International Inc
NYSE:MTD
26.8B USD 7.1 33.7 24.1 26.9
US
West Pharmaceutical Services Inc
NYSE:WST
24.1B USD 8.3 47.9 32.3 40.6
CN
WuXi AppTec Co Ltd
SSE:603259
164.4B CNY 4.3 20.4 14.8 14.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
M
MaxCyte Inc
NASDAQ:MXCT
Average EV/EBITDA: 174.9
Negative Multiple: -6.5
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 513.6
23%
66.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
21.2
19%
1.1
US
Danaher Corp
NYSE:DHR
26.7
22%
1.2
KR
Samsung Biologics Co Ltd
KRX:207940
34.3
57%
0.6
CH
Lonza Group AG
SIX:LONN
45.3
36%
1.2
US
Agilent Technologies Inc
NYSE:A
22.3
34%
0.7
US
IQVIA Holdings Inc
NYSE:IQV
14.1
32%
0.4
US
Mettler-Toledo International Inc
NYSE:MTD
24.1
16%
1.5
US
West Pharmaceutical Services Inc
NYSE:WST
32.3
16%
2
CN
WuXi AppTec Co Ltd
SSE:603259
14.8
52%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
M
MaxCyte Inc
NASDAQ:MXCT
Average EV/EBIT: 352
Negative Multiple: -5.9
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
3 225.5
130%
24.9
US
Thermo Fisher Scientific Inc
NYSE:TMO
30.4
57%
0.5
US
Danaher Corp
NYSE:DHR
40.1
59%
0.7
KR
Samsung Biologics Co Ltd
KRX:207940
49.4
76%
0.6
CH
Lonza Group AG
SIX:LONN
45.3
37%
1.2
US
Agilent Technologies Inc
NYSE:A
25.9
42%
0.6
US
IQVIA Holdings Inc
NYSE:IQV
21.5
70%
0.3
US
Mettler-Toledo International Inc
NYSE:MTD
26.9
22%
1.2
US
West Pharmaceutical Services Inc
NYSE:WST
40.6
13%
3.2
CN
WuXi AppTec Co Ltd
SSE:603259
14.8
23%
0.6

See Also

Discover More
Back to Top